[HTML] nih.gov

[HTML][HTML] Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma

LH Feng, HC Sun, XD Zhu, SZ Zhang… - Annals of …, 2021 - ncbi.nlm.nih.gov
Background The use of angiotensin II inhibitors is associated with a low risk of recurrence
and metastasis in hepatocellular carcinoma (HCC) patients. Vascular cell adhesion …
被引用次数：14 相关文章

Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma.

LH Feng, HC Sun, XD Zhu, SZ Zhang, XL Li… - Annals of …, 2021 - europepmc.org
Background The use of angiotensin II inhibitors is associated with a low risk of recurrence
and metastasis in hepatocellular carcinoma (HCC) patients. Vascular cell adhesion …
[PDF] amegroups.cn

[PDF][PDF] Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma

LH Feng, HC Sun, XD Zhu, SZ Zhang, XL Li, KS Li… - 2021 - cdn.amegroups.cn
Background: The use of angiotensin II inhibitors is associated with a low risk of recurrence
and metastasis in hepatocellular carcinoma (HCC) patients. Vascular cell adhesion …
[HTML] amegroups.org

[HTML][HTML] Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma

LH Feng, HC Sun, XD Zhu, SZ Zhang… - Annals of …, 2021 - atm.amegroups.org
Background: The use of angiotensin II inhibitors is associated with a low risk of recurrence
and metastasis in hepatocellular carcinoma (HCC) patients. Vascular cell adhesion …

Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma

LH Feng, HC Sun, XD Zhu… - Annals of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background The use of angiotensin II inhibitors is associated with a low risk of recurrence
and metastasis in hepatocellular carcinoma (HCC) patients. Vascular cell adhesion …
[PDF] amegroups.org

[PDF][PDF] Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma

LH Feng, HC Sun, XD Zhu, SZ Zhang… - Annals of …, 2021 - atm.amegroups.org
The ARRIVE Guidelines Checklist Page 1 3-1 Item Item No RECOMMENDATION Reported on
Page Number/Line Number Reported on Section/Paragraph Title 1 Provide as accurate and …

Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma.

LH Feng, HC Sun, XD Zhu, SZ Zhang, XL Li… - Annals of …, 2021 - europepmc.org
Background The use of angiotensin II inhibitors is associated with a low risk of recurrence
and metastasis in hepatocellular carcinoma (HCC) patients. Vascular cell adhesion …